Ratings Anshan Hifichem Co., Ltd.

Equities

300758

CNE100003JV6

End-of-day quote Shenzhen S.E. 06:00:00 2024-05-13 pm EDT 5-day change 1st Jan Change
13.8 CNY -6.95% Intraday chart for Anshan Hifichem Co., Ltd. +11.47% +36.50%

Strengths

  • Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 53% by 2026.
  • The earnings growth currently anticipated by analysts for the coming years is particularly strong.
  • Sales forecast by analysts have been recently revised upwards.
  • For several months, analysts have been revising their EPS estimates roughly upwards.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.

Weaknesses

  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 69 times its estimated earnings per share for the ongoing year.
  • In relation to the value of its tangible assets, the company's valuation appears relatively high.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: Specialty Chemicals

1st Jan change Capi. Investor Rating ESG Refinitiv
+36.50% 818M -
+9.17% 4.08B
D+
+8.03% 1.81B
B+
+23.43% 1.15B -
+8.03% 1.04B
D+
+65.59% 714M - -
-3.86% 697M - -
+34.34% 597M
B-
+11.13% 464M -
D+
-6.64% 424M - -
Investor Rating
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
-
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
-
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 300758 Stock
  4. Ratings Anshan Hifichem Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW